Assessment of RAS Dependency for BRAF Alterations Using Cancer Genomic Databases

Authors:

Abstract
BRAF alterations have been classified into class 1, 2, and 3 based on dimer formation, enzyme activity, and RAS dependence from in vitro experiments.1,2 Different classes of BRAF alterations differ in mechanism of action and require different treatment strategies.3-6 Class 3 alterations are different from class 1 (V600) and class 2 (non-V600 activating alterations) in that they are RAS-dependent with impaired kinase activity.1,2 Class 2 BRAF alterations were defined as RAS independent, and as activating BRAF alterations they are expected to be mutually exclusive to RAS alterations similar to class 1 BRAF alterations. However, some class 2 BRAF alterations were reported to coexist with RAS alterations.7,8 In contrast, class 3 BRAF variants, defined as RAS dependent, can be found without coexisting RAS alterations.7,8 Variation coexistence analysis using cancer genomics database provides evidence for functional interactions between activated RAS and BRAF alterations, and thus can support in vivo RAS dependency or independency. However, such analysis requires a large cancer genomics database, and most published clinical studies are limited in size to systematically assess RAS dependency with real-world clinical data.

This publication has 17 references indexed in Scilit: